Loading…

A case of successful management with splenectomy of intractable ascites due to congenital dyserythropoietic anemia type Ⅱ-induced cirrhosis

The congenital dyserythropoietic anemias comprise a group of rare hereditary disorders of erythropoiesis, characterized by ineffective erythropoiesis as the predominant mechanism of anemia and by characteristic morphological aberrations of the majority of erythroblasts in the bone marrow. Congenital...

Full description

Saved in:
Bibliographic Details
Published in:World journal of gastroenterology : WJG 2006-02, Vol.12 (5), p.818-821
Main Authors: Vassiliadis, Themistoklis, Garipidou, Vassilia, Perifanis, Vassilios, Tziomalos, Konstantinos, Giouleme, Olga, Patsiaoura, Kalliopi, Avramidis, Michalis, Nikolaidis, Nikolaos, Vakalopoulou, Sofia, Tsitouridis, Ioannis, Antoniadis, Antonios, Semertzidis, Panagiotis, Kioumi, Anna, Premetis, Evangelos, Eugenidis, Nikolaos
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The congenital dyserythropoietic anemias comprise a group of rare hereditary disorders of erythropoiesis, characterized by ineffective erythropoiesis as the predominant mechanism of anemia and by characteristic morphological aberrations of the majority of erythroblasts in the bone marrow. Congenital dyserythropoietic anemia type II is the most frequent type. All types of congenital dyserythropoietic anemias distinctly share a high incidence of iron loading. Iron accumulation occurs even in untransfused patients and can result in heart failure and liver cirrhosis. We have reported about a patient who presented with liver cirrhosis and intractable ascites caused by congenital dyserythropoietic anemia type II. Her clinical course was further complicated by the development of autoimmune hemolytic anemia. Splenectomy was eventually performed which achieved complete resolution of ascites, increase of hemoglobin concentration and abrogation of transfusion requirements.
ISSN:1007-9327
2219-2840
DOI:10.3748/wjg.v12.i5.818